GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (LTS:0GQU) » Definitions » Net Income From Continuing Operations

Active Biotech AB (LTS:0GQU) Net Income From Continuing Operations : kr-44.80 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Active Biotech AB Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Active Biotech AB's net income from continuing operations for the three months ended in Mar. 2024 was kr-10.50 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was kr-44.80 Mil.

Active Biotech AB Net Income From Continuing Operations Historical Data

The historical data trend for Active Biotech AB's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Net Income From Continuing Operations Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.13 -32.25 -49.83 -58.37 -45.80

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.50 -11.20 -10.60 -12.50 -10.50

Active Biotech AB Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-44.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB (LTS:0GQU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (LTS:0GQU) » Definitions » Net Income From Continuing Operations
Comparable Companies
OSTO:SANION OSTO:BIOVIC B OSTO:GUARD OSTO:ACOU OSTO:XINT OSTO:NICA OSTO:ABLI OSTO:CLBIO XSAT:CESSA OSTO:INDEX OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
ACTI:Sweden BTPC:Germany
Address
Scheelevagen 22, Lund, SWE, 223 63
Website
https://www.activebiotech.com
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (LTS:0GQU) Headlines

No Headlines